Regulatory Cell Therapy In Kidney Transplantation (The One Study): A Harmonised Design And Analysis Of Seven Non-Randomised, Single-Arm, Phase 1/2a Trials (Vol 395, Pg 1627, 2020) B Sawitzki , P N Harden , P Reinke , A Moreau , J A Hutchinson , D S Game , Q Tang , E C Guinan , M Battaglia , W J Burlingham , Roberts Isd. , M Streitz , R Josien , C A Boeger , C Scotta , J F Markmann , J L Hester , K Juerchott , C Braudeau , B James , L Contreras-Ruiz , J B van der Net , T Bergler , R Caldara , W Petchey , M Edinger , N Dupas , M Kapinsky , I Mutzbauer , N M Otto , R Oellinger , M P Hernandez-Fuentes , F Issa , N Ahrens , C Meyenberg , S Karitzky , U Kunzendorf , S J Knechtle , J Grinyo , P J Morris , L Brent , A Bushell , L A Turka , J A Bluestone , R I Lechler , H J Schlitt , S Schlickeiser , M C Cuturi , P J Friend , T Miloud , A Scheffold , A Secchi , K Crisalli , Kang S-M. , R Hilton , B Banas , G Blancho , Volk H-D. , G Lombardi , K J Wood , E K Geissler LANCET（2020）
Key words
regulatory cell therapy, kidney transplantation, trials, non-randomised, single-arm
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
